U.S. Markets closed

Sarepta Therapeutics: 2Q Earnings Snapshot

CAMBRIDGE, Mass. (AP) _ Sarepta Therapeutics Inc. (SRPT) on Wednesday reported a loss of $276.4 million in its second quarter.

The Cambridge, Massachusetts-based company said it had a loss of $3.74 per share.

The results did not meet Wall Street expectations. The average estimate of eight analysts surveyed by Zacks Investment Research was for a loss of $1.08 per share.

The biopharmaceutical company posted revenue of $94.7 million in the period, which beat Street forecasts. Eight analysts surveyed by Zacks expected $91.3 million.

Sarepta Therapeutics shares have climbed 30% since the beginning of the year. In the final minutes of trading on Wednesday, shares hit $142.26, an increase of 17% in the last 12 months.


This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on SRPT at https://www.zacks.com/ap/SRPT